Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy
Study sponsor: Edgewise Therapeutics, Inc. · EWTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-03Estimated
Enrollment · participants43Actual
Source updated2025-11-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.